Category Archives: Cardiac Surgery

VENICE A Venice Regional Bayfront Health nurse was awarded the national 2020 Nursing Excellence Award from Community Health Systems from the hospitals parent company, it announced. Dawn Beardsley-Shortt has been a registered nurse at Venice Regional Bayfront Health for 32 years. Continue reading →

Data Bridge Market ResearchAnalyst has added a new research study on TitleCardiac Surgery Instruments Market(COVID-19 Updated) Professional Survey Report with detailed information on market size, share, trends, growth, upcoming technology, innovation, business overview, andGlobal Cardiac Surgery Instruments industry scenario during the forecast period. Continue reading →

DEAR DR. ROACH: I am scheduled to play tennis with my friend tonight Continue reading →

New Jersey, United States: Market Research Intellect has added a new report to its huge database of research reports, entitled Cardiac Surgery and Interventional Cardiology Market Size and Forecast to 2027. The report offers a comprehensive assessment of the market including insights, historical data, facts, and industry-validated market data. Continue reading →

IndustryGrowthInsights (IGI) offers a detailed report on Global Cardiac Surgery Instruments Market. The report is a comprehensive research study that provides the scope of Cardiac Surgery Instruments market size, industry growth opportunities and challenges, current market trends, potential players, and expected performance of the market in regions for the forecast period from 2020 to 2027. This report highlights key insights on the market focusing on the possible requirements of the clients and assisting them to make right decision about their business investment plans and strategies. Continue reading →

Mortality risk in patients undergoing surgery for infective endocarditis (IE) significantly increases with age, with a mortality of 20% in patients aged 75 years or older, and is further augmented by previous cardiac surgery, heart valve implantation prior to IE admission, and diabetes, according to a study recently published in BMC Infectious Diseases. Continue reading →

Jack Eastwood was placed on a wait list for elective heart surgery in November 2019, and is still on it. After waiting for open-heart surgery for more than a year, a St. Continue reading →

KING OF PRUSSIA, Pa., Nov. Continue reading →

Vifor Pharma and Angion sign license agreement for ANG-3777 in nephrology indications Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG-3777 ANG-3777 is a first in class small-molecule hepatocyte growth factor (HGF) mimetic, addressing a significant unmet need for the treatment of delayed graft function and cardiac surgery-associated acute kidney injury Angion will receive up to USD 80 million, which includes 30 million upfront payment, 30 million equity investment and 20 million clinical study milestone payments with further milestone payments and tiered royalties on global sales - Vifor Pharma will host conference call and webcast today at 2:00 pm CET - St Gallen and Uniondale, NY, November 09, 2020 Vifor Pharma and Angion Biomedica Corp. (Angion) announced the signing of a licensing agreement for the commercialization of ANG-3777, currently developed for treatment of delayed graft function (DGF) and cardiac surgery-associated acute kidney injury (CSA-AKI). ANG-3777 was engineered to mimic the biological activity of HGF, activating critical pathways in the bodys natural organ repair process following an acute organ injury. Continue reading →

Cardiac Surgery Instruments Market Report The research study on the Global Cardiac Surgery Instruments Market is a thorough investigation of the value and supply chain of the market and offers all-inclusive data about the industry. Continue reading →